Kanoria Chemicals Reports Q1 FY26 Loss Amid Subsidiary Stake Dilution Plans
Kanoria Chemicals & Industries Limited reported a standalone net loss of ₹767.00 lakhs for Q1 FY26, compared to a profit of ₹64.00 lakhs in Q1 FY25. The company's revenue increased to ₹18,658.00 lakhs from ₹16,168.00 lakhs year-on-year. The Electronic Automotive segment suffered a loss of ₹968.00 lakhs. An exceptional item of ₹1,064.00 lakhs was recorded due to impairment of investment in APAG Holding AG. The Board approved a plan to reduce stake in APAG Holding AG from 55% to 14.3% through a USD 19.38 million transaction with strategic investors.

*this image is generated using AI for illustrative purposes only.
Kanoria Chemicals & Industries Limited , a prominent player in the chemical industry, has reported a significant financial setback in its first quarter results for the fiscal year 2026, coupled with strategic changes in its subsidiary holdings.
Financial Performance
The company announced a standalone net loss of ₹767.00 lakhs for the quarter ended June 30, 2025, a stark contrast to the profit of ₹64.00 lakhs recorded in the same quarter of the previous year. This downturn comes despite an increase in revenue from operations, which rose to ₹18,658.00 lakhs from ₹16,168.00 lakhs year-on-year.
On a consolidated basis, the situation appears more challenging, with the company reporting a loss of ₹1,378.00 lakhs for the quarter.
Segment Performance
Kanoria Chemicals operates across three segments: Chemicals, Electronic Automotive, and Textile. Notably, the Electronic Automotive segment reported a substantial loss of ₹968.00 lakhs during the quarter, contributing significantly to the overall negative performance.
Exceptional Item and Impairment
A key factor impacting the company's financial results was an exceptional item of ₹1,064.00 lakhs, attributed to the impairment of its investment in APAG Holding AG, a subsidiary of the company.
Strategic Divestment Plans
In a significant move, the Board of Directors has approved a proposal for diluting the company's stake in its subsidiary, APAG Holding AG. The plan involves reducing Kanoria Chemicals' ownership from the current 55% to approximately 14.3% through a strategic investor transaction valued at USD 19.38 million.
This divestment strategy is structured in two phases:
Phase 1: APAG will issue new equity shares against:
- Partial conversion of Kanoria Chemicals' loan of EUR 2.64 million
- Partial conversion of Cosyst Holding AG's (another shareholder) loan of CHF 4.95 million (EUR 5.27 million)
- Subscription from strategic investor(s) amounting to USD 19.38 million (EUR 17.78 million)
Phase 2: Expected in FY 2029-30, Kanoria Chemicals plans to transfer its remaining stake to strategic investor(s) based on an agreed valuation methodology.
Outlook
The company's financial performance, coupled with its strategic divestment plans, signals a period of significant transition for Kanoria Chemicals & Industries Limited. The move to dilute its stake in APAG Holding AG may be seen as an effort to streamline operations and potentially improve the company's financial position in the long term.
As the company navigates through these challenges and strategic changes, stakeholders will be keenly watching how these moves impact its future performance and market position in the chemical industry.
Historical Stock Returns for Kanoria Chemicals & Industries
1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|
+0.38% | -1.27% | -3.89% | +2.69% | -47.81% | +129.51% |